Texas Supreme Court Clears Path for State Hemp Restrictions After Overturning Industry Injunction
The ruling hands broad regulatory power to Texas health officials and puts the state’s $5.5 billion consumable hemp industry on notice.
CBDWorldNews Editorial Staff | May 11, 2026
A brief victory for Texas hemp businesses ended abruptly this week when the Texas Supreme Court overturned a Travis County temporary injunction that had blocked key parts of the state’s new hemp regulations. The decision gives the Texas Department of State Health Services full authority to enforce restrictions on hemp flower, concentrates, and products containing THCA and alternative forms of THC.
The Legal Rollercoaster
On May 1, Travis County Judge Daniella DeSeta Lyttle granted a temporary injunction that let hemp businesses keep selling cannabis flower and concentrates. The ruling also blocked sharply higher state fees charged to hemp manufacturers and retailers.
The injunction specifically stopped DSHS from enforcing a new “total delta-9 THC” testing standard that would have effectively banned most hemp flower and concentrates sold in the state.
Hemp businesses celebrated the ruling as a lifeline. Then the Texas Supreme Court stepped in.
“The DSHS commissioner has broad authority to regulate consumable hemp products in the interest of public health.” — Texas Supreme Court opinion
The high court found that the lower court had overstepped and that state law grants DSHS commissioners wide discretion in setting health and safety standards for consumable products.
What It Means for $5.5 Billion Industry
Texas built one of the nation’s largest consumable hemp markets after the 2018 Farm Bill opened the door for hemp products nationwide. Industry groups estimate the state’s hemp market generates $5.5 billion in annual revenue and supports thousands of jobs.
The Supreme Court ruling threatens a significant portion of that market. Products containing THCA, which converts to THC when heated, drove much of the growth in Texas hemp retail. Under the DSHS standards now enforceable, those products will likely be pulled from shelves.
Delta-8 THC products, already under scrutiny nationwide, face the most immediate impact. Texas retailers who stocked up on delta-8 inventory during the brief injunction window now face potential enforcement action.
For consumers looking for products that remain compliant under both federal and state rules, THC-free CBD options tested by independent laboratories offer the clearest path forward.
State-by-State Divergence Widens
The Texas decision highlights a growing split among states on hemp regulation. While Texas tightens restrictions, other states have moved to create regulated markets for intoxicating hemp products with age verification and product safety standards.
Colorado, Oregon, and Connecticut have each established frameworks that allow certain hemp-derived THC products with consumer protections in place. Minnesota created one of the most permissive hemp edibles programs in the country.
Texas is moving in the opposite direction, aligning more closely with the federal government’s November 2026 restrictions.
Business Impact
Small hemp retailers face the steepest challenges. Many built their entire business models around delta-8 and THCA products that now face enforcement. Unlike large multistate operators, small shops often lack the capital to pivot quickly to compliant product lines.
Several Texas hemp trade associations have announced plans to pursue further legal action, though the path forward after a Supreme Court loss is narrow. Legislative relief represents the most realistic option, but the Texas legislature does not convene in regular session again until 2027.
Some businesses are already adapting. Austin-based retailers report shifting inventory toward CBD isolate products, topicals, and wellness-focused formulations that fall well within compliance thresholds.
The Bigger Picture
The Texas ruling carries weight beyond state borders. Other states watching the legal battle may take the Supreme Court’s reasoning as precedent for granting their own health agencies broader regulatory authority over hemp products.
Combined with the federal hemp restrictions coming in November, the Texas decision accelerates a market-wide shift. The hemp industry’s growth phase, fueled largely by intoxicating products sold through the 2018 Farm Bill’s loopholes, appears to be closing.
What replaces it may be a smaller but more stable market focused on traditional CBD wellness products with clear regulatory pathways.
These statements have not been evaluated by the Food and Drug Administration. CBD products are not intended to diagnose, treat, cure, or prevent any disease.
